We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Boosting Tumor Cell Drug Sensitivity

News   Oct 31, 2018 | Original story from the University of California San Diego

 
Boosting Tumor Cell Drug Sensitivity

Pancreatic cancer cells deficient in the expression of the human gene known as Schlafen 11 and resistant to chemotherapy (left panels) were re-sensitized to chemotherapeutic treatment (middle and right panels) by inhibiting the expression of the transfer RNA known as tRNA-Leu-TAA through specially designed antisense oligonucleotides. Credit: Manqing Li, Michael David Lab, UC San Diego

 
 
Advertisement
 

RELATED ARTICLES

Scientists Use Novel Ink To 3D-Print Bone-Mimicking Structures

News

Scientists from UNSW Sydney have developed a ceramic-based ink that may allow surgeons in the future to 3D-print bone parts complete with living cells that could be used to repair damaged bone tissue.

READ MORE

Team Investigates Potential Drug Therapy Combination for Lung Cancer

News

Researchers report that in non-small-cell lung carcinoma, secondary mutations occurring with another gene alteration known as ALK make the efficacy of alectinib, an otherwise commonly used drug for treating lung cancer, become unfavorable. Combining alectinib with another drug could help to overcome these effects.

READ MORE

COVID-19 Pandemic Causes Dramatic Changes to the Delivery of Radiotherapy Treatments

News

New research, led by the University of Leeds, with Public Health England and the Royal College of Radiologists, reveals dramatic changes in the delivery of radiotherapy treatments for cancer during the first wave of the coronavirus pandemic in England.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE